175 results
Page 7 of 9
8-K
EX-99.1
olsbczk0 82
2 May 19
Agile Therapeutics Reports First Quarter 2019 Financial Results
4:25pm
8-K
EX-99.1
3l3xwj
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
nkuhvq2 xpqbzz2bsu
18 Mar 19
Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
4:31pm
8-K
EX-99.1
7x6jc0nb zkzb
12 Mar 19
Agile Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results
4:22pm
8-K
EX-99.1
1fgheri574
4 Mar 19
Agile Therapeutics Announces $7.8 Million Private Placement
5:27pm
8-K
EX-99.1
qrsey
11 Feb 19
Company now focused on completing plan to resubmit NDA in first half of 2019
5:00pm
424B5
zqna y4fz7
23 Jan 19
Prospectus supplement for primary offering
8:01am
8-K
EX-99.1
84mbh13
10 Jan 19
Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
4:20pm
8-K
EX-99.1
q84cj60ctg0w97bjj5j
7 Jan 19
Results of Operations and Financial Condition
8:01am
8-K
oiyym2
7 Jan 19
Results of Operations and Financial Condition
8:01am
8-K
EX-99.1
aewz4yri pvar
13 Dec 18
Expects to Announce Results of Meeting After Receipt of Final Minutes from FDA
4:45pm
8-K
EX-99.1
svua84
1 Nov 18
Agile Therapeutics Reports Third Quarter 2018 Financial Results
4:31pm
8-K
EX-99.1
2afhnrh4rxh gz
24 Oct 18
Other Events
8:13am
8-K
EX-99.2
vpsczskq6vtb9 od45e
24 Oct 18
Other Events
8:13am
8-K
rwf06lp2lsvblwc
24 Oct 18
Other Events
8:13am
8-K
EX-99.1
382d2gsf
9 Oct 18
Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
8:09am